Elizabeth Rostan, MD
Dermatology · Charlotte, NCNPI 1265522239
Payments from drug & device makers
Across 156 payments — averaging $63.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Merz North America, Inc.$2K
- Galderma Laboratories, L.p.$635
- Johnson & Johnson$363
- Novartis$247
- LEO Pharma Inc.$178
- plus $729 from 16 others
What the payments were for
- Speaking & faculty fees$4,82648%
- Food & beverage$4,94150%
- Education$2122%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $6,085 |
| Merz North America, Inc. | 12 | $1,743 |
| Galderma Laboratories, L.p. | 24 | $635 |
| Johnson & Johnson | 10 | $363 |
| Novartis | 13 | $247 |
| LEO Pharma Inc. | 7 | $178 |
| Lilly USA, LLC | 3 | $155 |
| Regeneron Healthcare Solutions, Inc. | 4 | $133 |
| Pfizer | 5 | $73 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $53 |
| Sanofi | 1 | $46 |
| Incyte Corporation | 2 | $40 |
| Journey Medical Corporation | 2 | $37 |
| Almirall LLC | 1 | $25 |
| UCB, Inc. | 1 | $23 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Sebela Pharmaceuticals Inc. | 1 | $17 |
| Biofrontera Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Organon | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$1,045
- ASCLERA$423
- BOTOX$147
- BOTOX COSMETIC$126
- COSENTYX$116
How this compares
$9,979 in reported general payments places this provider in the 75th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 20 | $830 |
| Dutasteride | 14 | $438 |
| Minoxidil | 23 | $204 |
| Triamcinolone Acetonide | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Charlotte
- Patrick McElgunnCharlotte$1.6M
- Deborah NixonCharlotte$906K
- Marc DarstCharlotte$829K
- Catherine PointonCharlotte$731K
- Gary SlaughterCharlotte$55K
- Rosalyn GeorgeWilmington$6.5M
- Steven FeldmanWinston Salem$4.3M
- Adnan NasirRaleigh$4.1M
- Christopher SayedChapel Hill$3.3M
- Zoe DraelosHigh Point$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.